UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013582
Receipt number R000015865
Scientific Title Study of the effect of packaged drug sets for eradication of Helicobacter pylori on the improvement of adherence.
Date of disclosure of the study information 2014/04/01
Last modified on 2015/01/24 17:43:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of the effect of packaged drug sets for eradication of Helicobacter pylori
on the improvement of adherence.

Acronym

Study of the effect of packaged drug sets for eradication of Helicobacter pylori
on the improvement of adherence.

Scientific Title

Study of the effect of packaged drug sets for eradication of Helicobacter pylori
on the improvement of adherence.

Scientific Title:Acronym

Study of the effect of packaged drug sets for eradication of Helicobacter pylori
on the improvement of adherence.

Region

Japan


Condition

Condition

atrophic gastritis, gastric ulcer, duodenal ulcer, MALToma, ITP, and early gastric cancer (post endoscopic therapy)

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate eradication rate, compliance, and comprehension of adverese effects in both packaged and non-packaged drug sets groups.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Compliance and comprehension of adverse effects

Key secondary outcomes

success rate of eradication


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

eradication therapy for 7days using packaged drug sets

Interventions/Control_2

eradication therapy for 7days using non packaged drug sets

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

patients over 20 years old who have any one of atrophic gastritis, gastric ulcer, duodenal ulcer, post endoscopit therapeutic gastric cancer, ITP, and gastric MALToma

Key exclusion criteria

patients who have any allergy to drugs
patients who have untreated gastric cancer
pregnant woman
nursing woman
patient who underwent upper gastrointestinal surgery

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masahito Aimi

Organization

Shimane University Faculty of medicine

Division name

Department of Gastroenterology and Hepatology

Zip code


Address

89-1, Enya-cho, Izumo-shi

TEL

0853-20-2190

Email

aimi@med.shimane-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masahito Aimi

Organization

Shimane University Faculty of medicine

Division name

Department of Gastroenterology and Hepatology

Zip code


Address

89-1, Enya-cho, Izumo-shi

TEL

0853-23-2111

Homepage URL


Email

aimi@med.shimane-u.ac.jp


Sponsor or person

Institute

Shimane University Faculty of medicine
Department of Gastroenterology and Hepatology

Institute

Department

Personal name



Funding Source

Organization

Shimane University Faculty of medicine
Department of Gastroenterology and Hepatology

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 05 Month 20 Day

Date of IRB


Anticipated trial start date

2013 Year 06 Month 26 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 03 Month 31 Day

Last modified on

2015 Year 01 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015865


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name